XML 15 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Series A Cumulative Preferred Stock
Common Stock
Additional Paid-in-Capital
Retained Earnings (Distributions in excess of net earnings)
Accumulated Other Comprehensive Income
Operating Partnership
Consolidated Joint Venture
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common shares of beneficial interest, shares outstanding     153,295,577          
Balance (in shares) at Dec. 31, 2024   12,879,475            
Balance at Dec. 31, 2024 $ 2,298,277 $ 366,936 $ 1,533 $ 2,992,487 $ (1,090,186) $ 13,788 $ 6,130 $ 7,589
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent 3,362              
Net income (loss) 3,172       3,362   (17) (173)
Unrealized gain (loss) on interest rate derivatives (5,296)         (5,296)    
Issuance of restricted stock (in shares)     1,197,751          
Issuance of restricted stock 0   $ 11 (11)        
Amortization of share-based compensation 4,730     4,730        
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock     $ (3)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (333,637)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (3,128)     (3,125)        
Shares acquired as part of a share repurchase program (in shares)     (2,233,049)          
Shares acquired as part of a share repurchase program (20,815)   $ (22) (20,793)        
Distributions on preferred shares (6,279)       (6,279)      
Distributions on common shares and units (23,048)       (22,941)   (107)  
Balance (in shares) at Mar. 31, 2025   12,879,475            
Balance at Mar. 31, 2025 $ 2,247,613 $ 366,936 $ 1,519 2,973,288 (1,116,044) 8,492 6,006 7,416
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common shares of beneficial interest, shares outstanding     151,926,642          
Common shares of beneficial interest, shares outstanding 151,085,078   151,085,078          
Balance (in shares) at Dec. 31, 2025   12,879,475            
Balance at Dec. 31, 2025 $ 2,182,660 $ 366,936 $ 1,511 2,977,616 (1,178,456) 1,919 5,696 7,438
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income (Loss) Attributable to Parent (141)              
Net income (loss) (349)       (141)   (34) (174)
Unrealized gain (loss) on interest rate derivatives 2,655         2,655    
Issuance of restricted stock (in shares)     1,290,109          
Issuance of restricted stock 0   $ 13 (13)        
Amortization of share-based compensation 4,140     4,140        
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock     $ (4)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (in shares)     (399,375)          
Shares acquired to satisfy minimum required federal and state tax withholding on vesting restricted stock (3,135)     (3,131)        
Distributions on preferred shares (6,279)       (6,279)      
Stock Issued During Period, Value, Conversion of Units 7           7  
Distributions on common shares and units (22,879)       (22,772)   (107)  
Balance (in shares) at Mar. 31, 2026   12,879,475            
Balance at Mar. 31, 2026 $ 2,156,806 $ 366,936 $ 1,520 $ 2,978,612 $ (1,207,648) $ 4,574 $ 5,548 $ 7,264
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Common shares of beneficial interest, shares outstanding 151,975,812   151,975,812